Please wait while the formulary information is being retrieved.
WAL-ACT D COLD & ALLERGY (PSEUDOEPHEDRINE HCL/TRIPROLIDINE HCL)
- Allergic rhinitis
- Cold symptoms
- Nasal congestion
- Allergic conjunctivitis
- Perennial allergic rhinitis
- Rhinorrhea
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
- Wal-act D Cold And Allergy Tablet
- Cold & Allergy Tablet
- Cold & Allergy Tab
- Aprodine Tablet
- By Indication
Wal-Act D Cold and Allergy 2.5 mg-60 mg tablet
- 1 tablet by oral route every 4-6 hours as needed
Cold and Allergy 4 mg-10 mg tablet
- Dosage information is not available
Cold and Allergy 4 mg-10 mg tablet
- Dosage information is not available
2.5 mg-60 mg tablet
- 1 tablet by oral route every 4-6 hours as needed
Nasal congestion
- 1 tablet by oral route every 4 hours as needed
- 1 tablet by oral route every 6 hours as needed
- 1 tablet by oral route every 4-6 hours as needed
Rhinorrhea
- 1 tablet by oral route every 4 hours as needed
- 1 tablet by oral route every 6 hours as needed
- 1 tablet by oral route every 4-6 hours as needed
Sneezing
- 1 tablet by oral route every 4 hours as needed
- 1 tablet by oral route every 6 hours as needed
- 1 tablet by oral route every 4-6 hours as needed
- isocarboxazid
- Marplan
- Matulane
- methylene blue (antidote)
- Nardil
- Parnate
- phenelzine
- procarbazine
- tranylcypromine
Contraindicated
- Azilect
- bromocriptine
- cabergoline
- Cafergot
- Cycloset
- D.h.e.45
- dihydroergotamine
- Eldepryl
- ergoloid
- Ergomar
- ergotamine tartrate
- ergotamine-caffeine
- linezolid
- methylergonovine
- Migergot
- Migranal
- Parlodel
- rasagiline
- selegiline HCl
- Zelapar
- Zyvox
Severe
Moderate
- methyldopa
- methyldopa-hydrochlorothiazide
- methyldopate
- reserpine
- Angle-closure glaucoma
- Severe coronary artery disease
- Severe uncontrolled hypertension
- Urinary retention
Contraindicated
- Angle-closure glaucoma
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Chronic idiopathic constipation
- Diabetes mellitus
- Hypertension
- Hyperthyroidism
- Stenosing peptic ulcer
- Urinary retention
Severe
Moderate
- Hypertension
- Hyperthyroidism
- Ocular hypertension
WAL-ACT D COLD & ALLERGY (PSEUDOEPHEDRINE HCL/TRIPROLIDINE HCL)
- Allergic rhinitis
- Cold symptoms
- Nasal congestion
- Allergic conjunctivitis
- Perennial allergic rhinitis
- Rhinorrhea
- Seasonal allergic rhinitis
- Sneezing
- Vasomotor rhinitis
- None
- Dizziness
- Drowsy
- Headache disorder
- Insomnia
- Thick bronchial secretions
More Frequent
Severe
Less Severe
- None
- Agitation
- Anorexia
- Dizziness
- Drowsy
- Dysuria
- General weakness
- Nausea
- Nervousness
- Pallor
- Sedation
- Tachycardia
- Tremor
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute generalized exanthematous pustulosis
- Anaphylaxis
- Blood dyscrasias
- Dyspnea
- Extrasystoles
- Hallucinations
- Hemolytic anemia
- Hypertension
- Hypotension
- Ischemic colitis
- Seizure disorder
- Vomiting
Less Severe
- Abdominal distension
- Abdominal pain with cramps
- Acute abdominal pain
- Acute confusion
- Anorexia
- Ataxia
- Blurred vision
- Cardiac arrhythmia
- Chest discomfort
- Chills
- Constipation
- Diarrhea
- Diplopia
- Dry nose
- Dry throat
- Dyspepsia
- Dyspnea
- Dysuria
- Euphoria
- Excitement
- Fatigue
- Headache disorder
- Hyperhidrosis
- Insomnia
- Irritability
- Maculopapular rash
- Malaise
- Migraine
- Nervousness
- Nightmares
- Palpitations
- Paresthesia
- Pruritus of skin
- Skin photosensitivity
- Skin rash
- Symptoms of anxiety
- Tachycardia
- Tinnitus
- Tremor
- Urinary retention
- Urticaria
- Vertigo
- Visual changes
- Wheezing
- Xerostomia
Contraindicated
Pseudoephedrine (Immed. Release)
High risk of adverse CNS effects. Not recommended for use age < 6 years.
Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 1 Day – 6 Years
- 1 High risk of adverse CNS effects. Not recommended for use age < 6 years.
- 1 Day – 119 Days
- 1 High risk of adverse CNS effects. Not recommended for use age < 6 years.
- 120 Days – 6 Years
- 1 High risk of adverse CNS effects. Not recommended for use age < 6 years.
Triprolidine
High risk of adverse CNS effects. Not recommended for use age < 6 years.
Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 1 Day – 6 Years
- 1 Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
- 1 Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 1 Day – 119 Days
- 1 Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
- 1 Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
- 120 Days – 6 Years
- 1 Use not recommended age <4 months. CNS excitation and seizure risk in newborns.
- 1 Risk of CNS & respiratory depression, excitation. Do not use age < 6 yr
Severe Precaution
None
Management or Monitoring Precaution
None
Pseudoephedrine
- Severity Level:
C
- Additional Notes: Fda c w/combo prod; poss risk of gastroschisis/sia with 1st trimester exposure
Triprolidine
- Severity Level:
C
- Additional Notes: Fda category c in combination product
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Pseudoephedrine
May decrease milk supply, and cause irritability
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Excreted | Drug shown to have adverse effect | May decrease milk supply, and cause irritability |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Pseudoephedrine
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating antihistamine preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | Y | Y | N | N |
BEERS: N HEDIS: N STOPP: N
Triprolidine
Cardiovascular-Elderly are more sensitive to tachycardia and hypertensive effects. May exacerbate symptomatic coronary insufficiency. Genitourinary-May cause urinary retention. Neuro/Psych-May worsen cognitive impairment in some elderly with dementia. Insomnia risk.
Neuro/Psych-Anticholinergic effects may cause sedation, worsen cognitive impairment and increase fall risk. Non-sedating antihistamine preferred. Gastrointestinal-May cause or worsen pre-existing constipation. Genitourinary-Best avoided in patients with urinary retention from any cause.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | N | N | N | Y | N | N |
BEERS: Y HEDIS: Y STOPP: Y
No Known Risk
None
- None
| Allergic conjunctivitis | |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| Cold symptoms | |
| J00 | Acute nasopharyngitis [common cold] |
| Nasal congestion | |
| R09.81 | Nasal congestion |
| Perennial allergic rhinitis | |
| J31.0 | Chronic rhinitis |
| Rhinorrhea | |
| R09.82 | Postnasal drip |
| Seasonal allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| Sneezing | |
| R06.7 | Sneezing |
| Vasomotor rhinitis | |
| J30.0 | Vasomotor rhinitis |
| 0-9 | A-Z |
|---|---|
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| J00 | Acute nasopharyngitis [common cold] |
| J30.0 | Vasomotor rhinitis |
| J30.1 | Allergic rhinitis due to pollen |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| J30.2 | Other seasonal allergic rhinitis |
| J30.5 | Allergic rhinitis due to food |
| J30.8 | Other allergic rhinitis |
| J30.81 | Allergic rhinitis due to animal (cat) (dog) hair and dander |
| J30.89 | Other allergic rhinitis |
| J30.9 | Allergic rhinitis, unspecified |
| J31.0 | Chronic rhinitis |
| R06.7 | Sneezing |
| R09.81 | Nasal congestion |
| R09.82 | Postnasal drip |
Formulary Reference Tool